Who Treats Adolescents and Young Adults with Cancer? A Report from the AYA HOPE Study (original) (raw)
2015, Journal of Adolescent and Young Adult Oncology
Physicians play a critical role in delivering effective treatment and enabling successful transition to survivorship among adolescent and young adult (AYA) cancer patients. However, with no AYA cancer medical specialty, information on where and by whom AYAs with cancer are treated is limited. Methods: Using the National Cancer Institute's population-based AYA HOPE Study, 464 AYAs aged 15-39 at diagnosis treated by 903 physicians were identified. Differences in physician and hospital characteristics were examined by age at diagnosis and cancer type (germ cell cancer, non-Hodgkin lymphoma, Hodgkin lymphoma, acute lymphocytic leukemia [ALL], and sarcoma) using chi-square tests. Results: Treating physicians were predominately 51-64 years old, male, United States-trained in non-pediatric specialties, and in group practices within large metropolitan areas. Older patients were less often treated by pediatric physicians (p < 0.01) and more likely to be treated by United States-trained physicians without research/teaching responsibilities and in hospitals without residency programs (p < 0.05). The majority of the few pediatricians (n = 44) treated ALL patients. Physicians with research/teaching responsibilities and those based in medical schools were more likely to treat patients with ALL and sarcoma compared with other cancer types (p < 0.01). Of HL patients, 73% were treated at a cancer center compared with 56% of patients with germ cell cancer (p < 0.01), while ALL (85%) and sarcoma (87%) patients were more likely to be treated in hospitals with residency programs (p < 0.01). Conclusions: Most AYAs with cancer were treated by non-pediatric physicians in community settings, although physician characteristics varied significantly by patient cancer type and age at diagnosis.
Sign up for access to the world's latest research
checkGet notified about relevant papers
checkSave papers to use in your research
checkJoin the discussion with peers
checkTrack your impact
Sign up for access to the world's latest research
Related papers
The Quid Pro Quo of pediatric versus adult services for older adolescent cancer patients
Pediatric Blood & Cancer, 2009
Data from the State of Georgia suggest that pediatric cancers have better survival outcomes when treated at pediatric cancer centers that are members of the nation&amp;amp;amp;amp;amp;amp;amp;#39;s Children&amp;amp;amp;amp;amp;amp;amp;#39;s Oncology Group (COG). To determine if the more adult types of cancer that occur in adolescents are better treated at centers with adult oncology expertise, the reported data were re-analyzed according to a scale that assessed whether the type of cancer was more likely to have been treated by oncologists with pediatric versus adult cancer experience. The results showed that survival hazard index was linearly correlated in 15- to 19-year-olds with the pediatric versus adult cancer type index (P &amp;amp;amp;amp;amp;amp;amp;lt; 0.0001). All of the five most pediatric type of cancers had a better survival at COG institutions and all of the three tumors with a better survival at non-COG institutions had the highest adult type scores. These results demonstrate that adolescent patients with pediatric types of cancer fare better when their care is conducted or supervised by oncologists who specialize in the care of their type of cancer. The Georgia data are among the first to indicate that the more adult type of cancers are better treated on an adult treatment regimen and/or under the supervision or in conjunction with adult-treating oncologists.
Adolescent and Young Adult Oncology
Clinical Journal of Oncology Nursing, 2013
Adolescent and young adult (AYA) oncology is caught between the pediatric and adult oncology settings and, therefore, poorly defined. Unfortunately, progress in overall survival for this age cohort has been stagnant while children and older adults have seen significant improvements. Reasons for the lack of progress are multifactorial, with biologic and psychosocial explanations. The current article will detail the unique features of AYA patients with cancer in terms of outcomes, psychosocial issues, and recommendations. Literature pertaining to AYA patients with cancer from 2006-2012 was reviewed. Findings suggested that recognizing AYAs as a subspecialty that requires holistic, multidisciplinary care may improve outcomes. Nurses at all levels are adept at providing holistic care and are, therefore, excellent potential advocates for a specialized care delivery model that AYAs with cancer deserve.
Single institution experience on cancer among adolescents 15-19 years of age
The Turkish journal of pediatrics, 2017
Yağcı-Küpeli B, Akyüz C, Yalçın B, Varan A, Kutluk T, Büyükpamukçu M. Single institution experience on cancer among adolescents 15-19 years of age. Turk J Pediatr 2017; 59: 1-5. Adolescent cancers differ from other age groups in terms of cancer types, treatment and outcome. We aimed to present our institutional data on survival of certain types of cancer in adolescents. Hospital files were retrospectively evaluated for distribution of tumor types, clinical features, and overall and event-free survival (OS and EFS) rates in adolescents with malignant tumors. Two hundred ninety-three cases between 15-19 years who were diagnosed with malignant tumor at our department in the last 38 years were included in the study. Mean age was 15.3 and median age was 15 years at time of diagnosis. Male/female ratio was found to be 1.8/1. The most common cancers were non-Hodgkin lymphoma (NHL) (20.5%), Hodgkin's lymphoma (HL) (19.8%), central nervous system (CNS) tumors (10.9%), osteosarcoma (10.6%...
South Asian Research Journal of Applied Medical Sciences, 2019
Purpose: Children with cancer arrive at treatment centers at advanced stages of the disease, with a survival rate of less than 30%. This study analyzes the path of children with cancer to the Hematology-Oncology Department of the Mother and Child Center of the Chantal Biya Foundation in Yaounde. Materials and methods: We conducted a descriptive cross-sectional study from November 2015 to July 2016 including all children aged 0 to 18 years with a confirmed diagnosis of cancer. Data was collected using a questionnaire. Results: We had 155 patients, with a sex ratio of 1.38. The median age was 6 years, with peaks of 2 months and 18 years. The must represented symptoms was fever (29.2%), followed by abdominal swelling (19.4%). The median number of resorts before the CME was 3 (2-4) with a minimum of 1 and a maximum of 15. 64.5% of children were brought to consultation in primary care to a general practitioner. 91 patients had at least three remedies: doctors (69.5%), healers and others (21.8%). The referral of children was mainly made by a pediatrician (29.5%). The average time between the onset of symptoms and consultation was 8 months. Patients came mostly at stages 3 and 4 at 51% and 39.4%, respectively. Conclusion: The majority of patients go to modern medicine. The time of arrival at the Service is long, the stages to the diagnosis very advanced.
Adolescent and young adult oncology patients: Disparities in access to specialized cancer centers
Cancer, 2017
Adolescents and young adults (AYAs) ages 15 to 39 years with cancer continue to experience disparate survival outcomes compared with their younger and older counterparts. This may be caused in part by differential access to specialized cancer centers (SCCs), because treatment at SCCs has been associated with improved overall survival. The authors examined social and clinical factors associated with AYA use of SCCs (defined as Children's Oncology Group-designated or National Cancer Institute-designated centers). A retrospective, population-based analysis was performed on all hospital admissions of AYA oncology patients in California during 1991 through 2014 (n = 127,250) using the Office of Statewide Health Planning and Development database. Multivariable logistic regression analyses examined the contribution of social and clinical factors on always receiving care from an SCC (vs sometimes or never). Results are presented as adjusted odds ratios (ORs) and 95% confidence intervals...
The management of cancer in the older adolescent
European Journal of Cancer, 2003
Cancer in adolescents 15-19 years of age occurs at nearly twice the rate observed in 5-to 14-year-olds, but as of yet they have no explicit organisation for research and care, such as that structured for younger paediatric patients. Adolescents with cancer must be recognised as a subgroup of oncology patients with specific characteristics and needs requiring dedicated interest and management. The need is made most evident as outcome data indicates that adolescents are lagging behind in survival gains made in recent decades by both children and adults with cancer. Improvements in the overall survival, quality of care and quality of survival of adolescents with cancer will only occur by surmounting the challenges, discussed in this review, unique to this group of patients.
Loading Preview
Sorry, preview is currently unavailable. You can download the paper by clicking the button above.